BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 78 filers reported holding BIODELIVERY SCIENCES INTL IN in Q4 2016. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,836,000 | -30.4% | 1,049,422 | +7.4% | 0.00% | – |
Q3 2016 | $2,639,000 | +14.4% | 977,251 | 0.0% | 0.00% | – |
Q2 2016 | $2,306,000 | -50.1% | 977,251 | -31.7% | 0.00% | -100.0% |
Q1 2016 | $4,621,000 | -31.6% | 1,430,567 | +1.4% | 0.00% | 0.0% |
Q4 2015 | $6,759,000 | +1.3% | 1,411,063 | +17.5% | 0.00% | 0.0% |
Q3 2015 | $6,675,000 | -33.9% | 1,200,520 | -5.4% | 0.00% | -50.0% |
Q2 2015 | $10,098,000 | -25.3% | 1,268,655 | -1.5% | 0.00% | 0.0% |
Q1 2015 | $13,517,000 | -12.6% | 1,287,344 | +0.0% | 0.00% | 0.0% |
Q4 2014 | $15,467,000 | -26.5% | 1,286,775 | +4.5% | 0.00% | -50.0% |
Q3 2014 | $21,036,000 | +38.2% | 1,230,875 | -2.4% | 0.00% | +33.3% |
Q2 2014 | $15,216,000 | +40.7% | 1,260,646 | -1.6% | 0.00% | +50.0% |
Q1 2014 | $10,816,000 | +51.7% | 1,281,474 | +5.9% | 0.00% | +100.0% |
Q4 2013 | $7,128,000 | +6.4% | 1,210,264 | -1.9% | 0.00% | 0.0% |
Q3 2013 | $6,702,000 | +35.9% | 1,234,240 | +1.6% | 0.00% | 0.0% |
Q2 2013 | $4,930,000 | – | 1,214,388 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 2,000,000 | $7,820,000 | 6.23% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $37,262,000 | 0.78% |
EMC Capital Management | 193,906 | $758,000 | 0.54% |
SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,486,454 | $13,632,000 | 0.50% |
ALGERT GLOBAL LLC | 344,210 | $1,346,000 | 0.43% |
Hillsdale Investment Management Inc. | 877,000 | $3,430,000 | 0.29% |
Stanley-Laman Group, Ltd. | 349,465 | $1,366,000 | 0.22% |
SHEPHERD KAPLAN KROCHUK, LLC | 94,000 | $368,000 | 0.14% |
GLOBEFLEX CAPITAL L P | 178,474 | $698,000 | 0.13% |
Zebra Capital Management LLC | 23,622 | $92,000 | 0.10% |